| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 187,1 k € | +10.9% | 168,7 k € | +2.6% | 164,5 k € | +41.4% | 116,3 k € | -18.4% | 142,5 k € | +5.3% | 135,4 k € | +7.5% | 126,0 k € | +9.4% | 115,2 k € | +114.6% | 53,7 k € | -15.0% | 63,2 k € | -57.1% | 147,5 k € | |
| EBITDA | 186,4 k € | +11.0% | 167,9 k € | +2.5% | 163,8 k € | +41.5% | 115,8 k € | -18.4% | 141,9 k € | +5.2% | 135,0 k € | +7.5% | 125,6 k € | +9.4% | 114,8 k € | +117.6% | 52,7 k € | -15.9% | 62,7 k € | -56.9% | 145,5 k € | |
| Operating profit | 167,6 k € | +9.7% | 152,7 k € | -0.1% | 152,9 k € | +46.0% | 104,7 k € | -21.2% | 132,9 k € | +2.3% | 130,0 k € | +8.5% | 119,8 k € | +10.2% | 108,7 k € | +128.6% | 47,6 k € | -23.8% | 62,4 k € | -56.7% | 144,0 k € | |
| Profit/loss | 134,6 k € | +15.1% | 116,9 k € | +8.5% | 107,8 k € | +45.7% | 74,0 k € | -21.5% | 94,3 k € | +0.6% | 93,7 k € | +9.5% | 85,6 k € | +12.0% | 76,4 k € | +132.0% | 32,9 k € | -20.5% | 41,4 k € | -58.1% | 98,7 k € | |
| Equity | 564,5 k € | -27.2% | 775,4 k € | +17.8% | 658,4 k € | +14.4% | 575,6 k € | +6.3% | 541,6 k € | +21.1% | 447,3 k € | +26.5% | 353,6 k € | +31.9% | 268,0 k € | +39.9% | 191,7 k € | +20.7% | 158,7 k € | +35.3% | 117,3 k € | |
| Total assets | 571,0 k € | -29.5% | 810,1 k € | +16.5% | 695,4 k € | +11.4% | 624,3 k € | +3.5% | 603,2 k € | +25.2% | 481,6 k € | +22.3% | 393,7 k € | +38.0% | 285,3 k € | +37.1% | 208,2 k € | -3.0% | 214,6 k € | +37.6% | 155,9 k € | |
| Cash | 135,2 k € | +952.6% | 12,8 k € | -95.2% | 265,3 k € | -52.5% | 558,9 k € | +4.3% | 535,8 k € | +19.4% | 448,9 k € | +28.9% | 348,3 k € | +38.6% | 251,4 k € | +53.1% | 164,2 k € | +16.3% | 141,2 k € | +67.7% | 84,2 k € | |
| Debts | 6,5 k € | -76.4% | 27,7 k € | -21.1% | 35,1 k € | -27.9% | 48,7 k € | -20.9% | 61,6 k € | +93.6% | 31,8 k € | +1.5% | 31,3 k € | +128.5% | 13,7 k € | -3.4% | 14,2 k € | -74.6% | 55,9 k € | +44.8% | 38,6 k € | |
Private limited company · Oudsbergen · incorporated on 14/03/2014
Private limited company profitable and well capitalised. Cash position rising (+952.6%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DR. ANN GABRIËLS is a Private limited company incorporated in 2014. Its main activity is: Other human health activities. Its registered office is in Oudsbergen.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.